Iovance Biotherapeutics Aktie

2,02 EUR -0,02 EUR -1,10 %

15:48:17

STU

2,34 USD -0,05 USD -2,09 %

15:59:02

BTT

Iovance Biotherapeutics jetzt ohne Ordergebühren (zzgl. Spreads) handeln beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)

Jetzt loslegen

Direkt handeln

Bei einem anderen Broker handeln

Marktkap.833,97 Mio. EUR

Div. Rendite0,00%

WKNA2DT49

ISINUS4622601007

SymbolIOVA

Iovance Biotherapeutics Aktien News

Sortieren:Datum Meistgelesen

11.11.25MotleyFoolDown 75% in 12 Months, Can Iovance Biotherapeutics Stock Turn Things Around?

06.11.25ZacksIovance Biotherapeutics (IOVA) Reports Q3 Loss, Lags Revenue Estimates

17.10.25MotleyFoolBetter Beaten-Down Stock: Iovance Biotherapeutics vs. Teladoc Health

WerbungIovance Biotherapeutics-Aktie für 0 Euro (zzgl. Spreads) handeln bei finanzen.net zero

13.10.25MotleyFoolIs Iovance Biotherapeutics Stock Your Ticket to Becoming a Millionaire?

25.08.25MotleyFoolWhy Iovance Biotherapeutics Stock Got Mashed on Monday

19.08.25MotleyFoolWhy Iovance Biotherapeutics Stock Was Climbing Today

09.08.25MotleyFoolWhy Iovance Biotherapeutics Stock Plummeted Today

08.08.25BenzingaWhat 7 Analyst Ratings Have To Say About Iovance Biotherapeutics

08.08.25BenzingaIovance Biotherapeutics Declines 29% In Premarket Trading: Here's What's Happening

07.08.25ZacksIovance Biotherapeutics (IOVA) Reports Q2 Loss, Lags Revenue Estimates

30.07.25MotleyFoolIs Iovance Biotherapeutics Stock Due for a Big Rally?

14.07.25PR NewswireLost Money on Iovance Biotherapeutics, Inc.(IOVA)? Join Class Action Suit Seeking Recovery - Contact The Gross Law Firm

14.07.25PR NewswireIOVA Investors Have Opportunity to Lead Iovance Biotherapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm

13.07.25PR NewswireIOVA Deadline: IOVA Investors with Losses in Excess of $100K Have Opportunity to Lead Iovance Biotherapeutics, Inc. Securities Fraud Lawsuit

12.07.25PR NewswireINVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Iovance Biotherapeutics, Inc. of Class Action Lawsuit and Upcoming Deadlines - IOVA

07.07.25PR NewswireIOVA Investors Have Opportunity to Lead Iovance Biotherapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm

02.07.25PR NewswireIOVA Investors Have Opportunity to Lead Iovance Biotherapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm

28.06.25MotleyFoolWhy Iovance Biotherapeutics Stock Dove by Almost 15% This Week

27.06.25PR NewswireINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Iovance Biotherapeutics, Inc. - IOVA

24.06.25PR NewswireIovance Biotherapeutics, Inc. (IOVA) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit

22.06.25PR NewswireINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Iovance Biotherapeutics, Inc. - IOVA

17.06.25PR NewswireINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Iovance Biotherapeutics, Inc. - IOVA

16.06.25PR NewswireIOVA Investors Have Opportunity to Lead Iovance Biotherapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm

13.06.25PR NewswireIOVA Shareholders Have the Right to Lead the Iovance Biotherapeutics, Inc. Securities Lawsuit - Contact the DJS Law Group to Discuss Your Rights - ELV

13.06.25PR NewswireIOVA Investors Have Opportunity to Lead Iovance Biotherapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm

12.06.25PR NewswireINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Iovance Biotherapeutics, Inc. - IOVA

01.06.25PR NewswireINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Iovance Biotherapeutics, Inc. - IOVA

28.05.25PR NewswireIOVA Investors Have Opportunity to Lead Iovance Biotherapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm

28.05.25PR NewswireIOVA Investors Have Opportunity to Lead Iovance Biotherapeutics, Inc. Securities Fraud Lawsuit

23.05.25PR NewswireIOVA Investors Have Opportunity to Lead Iovance Biotherapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm

21.05.25MotleyFoolDown More Than 75% This Year, Should Investors Throw in the Towel on Iovance Biotherapeutics Stock?

20.05.25PR NewswireINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Iovance Biotherapeutics, Inc. - IOVA

19.05.25PR NewswireIOVA INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Iovance Biotherapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

19.05.25PR NewswireIOVA Investors Have Opportunity to Lead Iovance Biotherapeutics, Inc. Securities Fraud Lawsuit

17.05.25MotleyFoolWhy Iovance Biotherapeutics Tumbled by Nearly 6% Today

09.05.25MotleyFoolWhy Iovance Biotherapeutics Stock Is Crashing Today

09.05.25BenzingaExpert Outlook: Iovance Biotherapeutics Through The Eyes Of 9 Analysts

08.05.25ZacksIovance Biotherapeutics (IOVA) Reports Q1 Loss, Misses Revenue Estimates

23.04.25MotleyFoolIovance Biotherapeutics Stock Is Crashing. And Here's Why Things Could Get Even Worse This Year.

14.04.25MotleyFoolIs Iovance Biotherapeutics a Millionaire-Maker?

Iovance Biotherapeutics News

Iovance Biotherapeutics News: auf dieser Seite finden Sie alle Iovance Biotherapeutics News und Nachrichten zur Iovance Biotherapeutics Aktie. Dies beinhaltet die Agentur-Feeds auf finanzen.net, aber auch Iovance Biotherapeutics News auf einer Vielzahl externer Seiten. Externe Links sind am entsprechenden Link-Symbol zu erkennen. Um Iovance Biotherapeutics News auf externen Seiten zu lesen, folgen Sie einfach dem entsprechenden Link.